Hepatic manifestations in systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a multi-organic autoimmune disease with a wide variety of clinical manifestations. However, hepatic dysfunction is not included in the diagnostic criteria for the disease and has not been recognized properly. The spectrum of hepatic involvement described in thes...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Lupus Ročník 29; číslo 8; s. 813
Hlavní autori: González-Regueiro, José A, Cruz-Contreras, Mariana, Merayo-Chalico, Javier, Barrera-Vargas, Ana, Ruiz-Margáin, Astrid, Campos-Murguía, Alejandro, Espin-Nasser, May, Martínez-Benítez, Braulio, Méndez-Cano, Victor H, Macías-Rodríguez, Ricardo U
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 01.07.2020
Predmet:
ISSN:1477-0962, 1477-0962
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Systemic lupus erythematosus (SLE) is a multi-organic autoimmune disease with a wide variety of clinical manifestations. However, hepatic dysfunction is not included in the diagnostic criteria for the disease and has not been recognized properly. The spectrum of hepatic involvement described in these patients ranges from abnormalities in liver function tests (LFTs) to fulminant hepatic failure. Usually, abnormalities in LFTs are only mild and transient, have a hepatocellular pattern and are not related to SLE but rather are mostly drug related. The most frequent finding on liver biopsy is steatosis (non-alcoholic fatty liver disease). Patients do not frequently progress to advanced chronic liver disease, and their outcome is favourable. Those who develop cirrhosis have traditional risk factors, such as other non-SLE-related conditions. In this work, we aim to review hepatic manifestations in patients with SLE, as well as the diagnostic and therapeutic approaches used for different liver diseases in these patients.
AbstractList Systemic lupus erythematosus (SLE) is a multi-organic autoimmune disease with a wide variety of clinical manifestations. However, hepatic dysfunction is not included in the diagnostic criteria for the disease and has not been recognized properly. The spectrum of hepatic involvement described in these patients ranges from abnormalities in liver function tests (LFTs) to fulminant hepatic failure. Usually, abnormalities in LFTs are only mild and transient, have a hepatocellular pattern and are not related to SLE but rather are mostly drug related. The most frequent finding on liver biopsy is steatosis (non-alcoholic fatty liver disease). Patients do not frequently progress to advanced chronic liver disease, and their outcome is favourable. Those who develop cirrhosis have traditional risk factors, such as other non-SLE-related conditions. In this work, we aim to review hepatic manifestations in patients with SLE, as well as the diagnostic and therapeutic approaches used for different liver diseases in these patients.Systemic lupus erythematosus (SLE) is a multi-organic autoimmune disease with a wide variety of clinical manifestations. However, hepatic dysfunction is not included in the diagnostic criteria for the disease and has not been recognized properly. The spectrum of hepatic involvement described in these patients ranges from abnormalities in liver function tests (LFTs) to fulminant hepatic failure. Usually, abnormalities in LFTs are only mild and transient, have a hepatocellular pattern and are not related to SLE but rather are mostly drug related. The most frequent finding on liver biopsy is steatosis (non-alcoholic fatty liver disease). Patients do not frequently progress to advanced chronic liver disease, and their outcome is favourable. Those who develop cirrhosis have traditional risk factors, such as other non-SLE-related conditions. In this work, we aim to review hepatic manifestations in patients with SLE, as well as the diagnostic and therapeutic approaches used for different liver diseases in these patients.
Systemic lupus erythematosus (SLE) is a multi-organic autoimmune disease with a wide variety of clinical manifestations. However, hepatic dysfunction is not included in the diagnostic criteria for the disease and has not been recognized properly. The spectrum of hepatic involvement described in these patients ranges from abnormalities in liver function tests (LFTs) to fulminant hepatic failure. Usually, abnormalities in LFTs are only mild and transient, have a hepatocellular pattern and are not related to SLE but rather are mostly drug related. The most frequent finding on liver biopsy is steatosis (non-alcoholic fatty liver disease). Patients do not frequently progress to advanced chronic liver disease, and their outcome is favourable. Those who develop cirrhosis have traditional risk factors, such as other non-SLE-related conditions. In this work, we aim to review hepatic manifestations in patients with SLE, as well as the diagnostic and therapeutic approaches used for different liver diseases in these patients.
Author Cruz-Contreras, Mariana
Martínez-Benítez, Braulio
González-Regueiro, José A
Ruiz-Margáin, Astrid
Macías-Rodríguez, Ricardo U
Espin-Nasser, May
Barrera-Vargas, Ana
Campos-Murguía, Alejandro
Méndez-Cano, Victor H
Merayo-Chalico, Javier
Author_xml – sequence: 1
  givenname: José A
  orcidid: 0000-0001-5211-4710
  surname: González-Regueiro
  fullname: González-Regueiro, José A
  organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
– sequence: 2
  givenname: Mariana
  surname: Cruz-Contreras
  fullname: Cruz-Contreras, Mariana
  organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
– sequence: 3
  givenname: Javier
  orcidid: 0000-0002-5870-0523
  surname: Merayo-Chalico
  fullname: Merayo-Chalico, Javier
  organization: Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
– sequence: 4
  givenname: Ana
  surname: Barrera-Vargas
  fullname: Barrera-Vargas, Ana
  organization: Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
– sequence: 5
  givenname: Astrid
  surname: Ruiz-Margáin
  fullname: Ruiz-Margáin, Astrid
  organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
– sequence: 6
  givenname: Alejandro
  surname: Campos-Murguía
  fullname: Campos-Murguía, Alejandro
  organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
– sequence: 7
  givenname: May
  surname: Espin-Nasser
  fullname: Espin-Nasser, May
  organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
– sequence: 8
  givenname: Braulio
  surname: Martínez-Benítez
  fullname: Martínez-Benítez, Braulio
  organization: Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
– sequence: 9
  givenname: Victor H
  surname: Méndez-Cano
  fullname: Méndez-Cano, Victor H
  organization: Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
– sequence: 10
  givenname: Ricardo U
  orcidid: 0000-0002-7637-4477
  surname: Macías-Rodríguez
  fullname: Macías-Rodríguez, Ricardo U
  organization: Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32390496$$D View this record in MEDLINE/PubMed
BookMark eNpNj81LxDAQxYOsuB969yQ9eqnOJGk-jrK4rrDgRc9lNk2w0rS1aQ_731twBU8z783j8Zs1W7Rd6xm7RXhA1PoRrEIOQnCwXAhrLtgKpdb57PPFv33J1il9AYBAq67YUnBhQVq1Ymrvexprl0Vq6-DTOIuuTVndZumURh_nUzP1U8r8cBo_faSxS1O6ZpeBmuRvznPDPnbP79t9fnh7ed0-HXInVDHmBlUwzlTO2BC8B6yOQTsZCJyZGbRSKAwpEgRaElQoq6AxVBiUpMIQ37D7395-6L6nGa-MdXK-aaj13ZRKLgERTcH1HL07R6dj9FXZD3Wk4VT-_cp_AFY1WDs
CitedBy_id crossref_primary_10_1016_j_cca_2023_117609
crossref_primary_10_1177_09612033241233021
crossref_primary_10_1097_MD_0000000000036999
crossref_primary_10_1111_cei_13512
crossref_primary_10_1186_s12887_024_04713_2
crossref_primary_10_7759_cureus_35494
crossref_primary_10_3390_ijms25169034
crossref_primary_10_1016_j_path_2023_04_003
crossref_primary_10_29333_ejgm_15670
crossref_primary_10_1186_s12967_024_05247_y
crossref_primary_10_1186_s10020_022_00510_8
crossref_primary_10_3389_fendo_2022_920283
crossref_primary_10_1007_s00296_020_04717_y
crossref_primary_10_1016_j_autrev_2024_103722
crossref_primary_10_1007_s10067_025_07613_7
crossref_primary_10_1016_j_intimp_2025_114898
crossref_primary_10_1016_j_hermed_2024_100972
crossref_primary_10_1016_j_jceh_2023_101339
crossref_primary_10_3389_fped_2023_1296426
crossref_primary_10_3748_wjg_v28_i23_2527
crossref_primary_10_1186_s13287_025_04208_6
crossref_primary_10_1016_j_reumae_2024_10_003
crossref_primary_10_4103_jmedsci_jmedsci_24_25
crossref_primary_10_1111_sji_70018
crossref_primary_10_3390_jcm10173820
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1177/0961203320923398
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1477-0962
ExternalDocumentID 32390496
Genre Journal Article
Review
GroupedDBID ---
-TM
.2E
.2F
.2G
.2J
.2N
.GJ
01A
0R~
18M
1~K
29L
31R
31S
31U
31X
31Y
31Z
36B
39C
4.4
53G
54M
5GY
5VS
7X7
88E
8FI
8FJ
8R4
8R5
AABMB
AABOD
AACKU
AACMV
AACTG
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJOX
AAJPV
AAKGS
AANSI
AAPEO
AAQDB
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWP
ABCCA
ABCJG
ABDBF
ABDWY
ABEIX
ABFWQ
ABHKI
ABHQH
ABJIS
ABKRH
ABLUO
ABOCM
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACFYK
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACLZU
ACOFE
ACOXC
ACPRK
ACROE
ACRPL
ACSIQ
ACUAV
ACUHS
ACUIR
ACXKE
ACXMB
ADBBV
ADDLC
ADEIA
ADMPF
ADNBR
ADNMO
ADNON
ADRRZ
ADTBJ
ADUCT
ADUKL
ADVBO
ADYCS
ADZZY
AECGH
AECVZ
AEDTQ
AEGXH
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFKBI
AFKRA
AFKRG
AFMOU
AFOSN
AFQAA
AFUIA
AFWMB
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AGWNL
AHDMH
AHMBA
AIAGR
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
ALTZF
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AUVAJ
AVWKF
AYAKG
AZFZN
AZQEC
B3H
B8M
B8O
B8R
B8Z
B93
B94
BBRGL
BDDNI
BENPR
BKIIM
BKNYI
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
BYIEH
C45
CBRKF
CCPQU
CDWPY
CFDXU
CGR
CORYS
CQQTX
CS3
CUTAK
CUY
CVF
DB0
DC-
DC0
DD-
DD0
DE-
DF0
DO-
DOPDO
DU5
DV7
DV9
D~Y
EAD
EAP
EBC
EBD
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
FEDTE
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HZ~
J8X
K.F
K.J
K9-
M0R
M1P
M4V
N9A
NPM
O9-
OVD
P.B
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q1R
Q2X
Q7K
Q7L
Q7R
Q7U
Q7X
Q82
Q83
ROL
S01
SAUOL
SCNPE
SDB
SFB
SFC
SFK
SFN
SFT
SGA
SGO
SGP
SGR
SGV
SGX
SGZ
SHG
SNB
SPJ
SPQ
SPV
SQCSI
STM
SV3
TEORI
TUS
UKHRP
ZONMY
ZPPRI
ZRKOI
ZSSAH
7X8
AAPII
ABIDT
ABJZC
ADEBD
AJGYC
AJHME
AJVBE
SASJQ
ID FETCH-LOGICAL-c365t-816f8c8dc89ffee01dbf7c4fa0c8323766138a6a3a074a0d14df71fd1f64a58a2
IEDL.DBID 7X8
ISICitedReferencesCount 24
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000534006800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1477-0962
IngestDate Sun Nov 09 14:25:31 EST 2025
Thu Apr 03 07:04:24 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Systemic lupus erythematosus
autoimmune liver disease
hepatic involvement
hepatitis
abnormal liver tests
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c365t-816f8c8dc89ffee01dbf7c4fa0c8323766138a6a3a074a0d14df71fd1f64a58a2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-7637-4477
0000-0001-5211-4710
0000-0002-5870-0523
PMID 32390496
PQID 2401118527
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2401118527
pubmed_primary_32390496
PublicationCentury 2000
PublicationDate 2020-Jul
20200701
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-Jul
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Lupus
PublicationTitleAlternate Lupus
PublicationYear 2020
SSID ssj0003196
Score 2.4068573
SecondaryResourceType review_article
Snippet Systemic lupus erythematosus (SLE) is a multi-organic autoimmune disease with a wide variety of clinical manifestations. However, hepatic dysfunction is not...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 813
SubjectTerms Humans
Liver - pathology
Liver Diseases - complications
Liver Diseases - etiology
Liver Diseases - therapy
Liver Function Tests
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - physiopathology
Title Hepatic manifestations in systemic lupus erythematosus
URI https://www.ncbi.nlm.nih.gov/pubmed/32390496
https://www.proquest.com/docview/2401118527
Volume 29
WOSCitedRecordID wos000534006800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JasMwEB3appReui_phgu9iniRJflUSmnIJSGHFnIzshYIFDuJ4kL_viPbIadCoRdfjEGMZnnSG88DeIo0gtYiYUQWlBEqNYYUpSmRKc80DQ0GoW7EJvhkImazbNpduLmurXKTE5tErSvl78gHWHkwLEUa8-fFknjVKM-udhIau9BLEMp4r-az7bRw717N30WcE4Tq8ZamHHilkzhMkjhEhJNk4neA2RSa4fF_l3gCRx3EDF5anziFHVOewcG4I9HPgY2Mb6NWgR99YY1ryXgXzMugneuMrz7rRe0Cs_puh7pWrnYX8DF8e38dkU4-gaiEpWsiImaFElqJzFpjwkgXlitqZagwjDGxYCUXkslEIoyQoY6otjyyOrKMylTI-BL2yqo01xAULIu11FQxgxtoWYEggbOUKkV9fjR9eNxYJEf39JyDLE1Vu3xrkz5ctWbNF-0cjRwXkeEBhd384etbOIz9SbdplL2DnsXgNPewr77Wc7d6aPYdn5Pp-AeTJ7eG
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatic+manifestations+in+systemic+lupus+erythematosus&rft.jtitle=Lupus&rft.au=Gonz%C3%A1lez-Regueiro%2C+Jos%C3%A9+A&rft.au=Cruz-Contreras%2C+Mariana&rft.au=Merayo-Chalico%2C+Javier&rft.au=Barrera-Vargas%2C+Ana&rft.date=2020-07-01&rft.issn=1477-0962&rft.eissn=1477-0962&rft.volume=29&rft.issue=8&rft.spage=813&rft_id=info:doi/10.1177%2F0961203320923398&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0962&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0962&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0962&client=summon